US Patent 7172763 Post-operative pain treatment by peripheral administration of a neurotoxin
Patent 7172763 was granted and assigned to Allergan, Inc. on February, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Kei Roger Aoki0
Minglei Cui0
Stephen W. Jenkins0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+183 characters)
Article
Patent abstract
Methods for treating a non-spasm caused pain by peripheral administration to a patient of a therapeutically effective amount of a neurotoxin, such as a botulinum toxin.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07172763 Post-operative pain treatment by peripheral administration of a neurotoxin US Patent 7172763 Post-operative pain treatment by peripheral administration of a neurotoxin
Infobox
Patent Number
071727630
Patent Number
71727630
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071727630
Date of Patent
February 6, 2007
0Patent Application Number
106305870
Date Filed
July 29, 2003
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07172763 Post-operative pain treatment by peripheral administration of a neurotoxin
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07172763
Date of patent
February 6, 2007
Patent application number
10630587
Date Filed
July 29, 2003
Patent primary examiner
Find more entities like US Patent 7172763 Post-operative pain treatment by peripheral administration of a neurotoxin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
